A study showed that miR-203 induces the apoptosis of YD-38 human oral cancer cells by directly targeting semaphorin 6A (SEMA6A), suggesting its potential application in anticancer therapeutics [122]. The gene discussed is SEMA6A; the disease is lip and oral cavity carcinoma.